Browsing: SRS

Top Line: What is the risk of hypopituitarism after SRS for nonfunctioning pituitary tumors?The Study: This large, multicenter retrospective study…

In the PERMEATE trial, the combination of pyrotinib (a small molecule TKI that targets HER1, ERBB2, and HER4) and capecitabine…

Top Line: Do antibody drug conjugates increase the risk of radiation necrosis for patients receiving SRS for brain mets?The Study:…

Top Line: What is the intracranial activity of chemoimmunotherapy for untreated NSCLC brain metastases? The Study: Systemic therapy won’t be…

Top Line:Tucatinib is increasingly used as part of combination systemic therapy for metastatic HER2+ breast cancer with impressive intracranial activity.…

Here is an excellent review on the use of stereotactic radiosurgery to treat non-malignant ailments such as intractable pain, epilepsy,…

Is there a difference in outcome between single fraction and multi-fraction SRS for meningioma? This systematic review and meta-analysis identified…

The same group again shows that immune checkpoint inhibition is fine during radiosurgery. What’s more interesting was the clear correlation…